LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH MYOCARDIAL INFARCTION

Authors

  • Istamova Sitora Saidkulovna
  • Tashkenbaeva Eleanorа Negmatovna
  • Fatullayevа Dilnoza Sayfullaeva
  • Murotkobilov Ozod Anvarovich
  • Alikulov Xusan Rahimbekovich
  • Kadirova Farzona Shuhratovna

Keywords:

diastolic dysfunction, heart failure, ejection fraction, echocardiography

Abstract

   Although the existence of diastole became known at the beginning of the last century, for a long time it was perceived as a simple interval during which the chambers of the heart are passively filled for the subsequent injection cycle. The prognostic value of LV systolic function has been comprehensively studied, and relatively little is known about the effect of diastolic dysfunction on the prognosis of patients with LV. To date, only a few publications contain information about the optimal time frame in which LV DF indicators acquire the greatest prognostic value. The contribution of diastolic dysfunction to the development of CHF after MI in patients with preserved systolic function remains poorly understood. After MI, LV diastolic dysfunction is considered to be the earliest marker preceding the expanded picture of CHF. At the same time, according to many researchers, the type of LV diastolic dysfunction corresponds to the severity of CHF manifestations.                                                                                                             

        The development of pathology occurs before the development of the appearance of the clinic and symptoms, as well as therapeutic effects on the mechanisms, which makes it difficult to study, due to insufficient information. Numerous studies state that the following risk factors prevail for the development of diastolic heart failure against the background of IHD, such as female gender, the presence of concomitant pathology in the form of diabetes mellitus, obesity, arterial hypertension, metabolic syndrome and others.

References

Бейшенкулов М. Т., Абдурашидова Т. Ш., Калиев К. Р., Токтосунова А. К., Тагаева А. К. Роль объемной нагрузки в оценке диастолического резерва левого желудочка и в прогнозировании развития сердечной недостаточности у больных инфарктом миокарда. Российский кардиологический журнал 2016, 8 (136) :31–35 http://dx.doi.org/10.15829/1560-4071-2016-8-31-35

Вдовенко Д.В., Либис Р.А. Показатели деформации миокарда и диастолическая функция левого желудочка у больных хронической сердечной недостаточностью с сохраненной фракцией выброса. Артериальная гипертензия. 2018;24(1):74–80. doi:10.18705/1607-419X-2018-24-1-74-80)

Гайфулин Р.А., Сумин А.Н., Архипов О.Г. Оценка диастолической функции правого желудочка у больных ишемической болезнью сердца в разных возрастных группах. Рациональная фармакотерапия в кардиологии 2016;12(3):277-284 DOI: http://dx.doi.org/10.20996/1819-6446-2016-12-3-277-284

Крикунов П. В., Васюк Ю. А., Крикунова О. В. Прогностическая значимость эхокардиографии после острого инфаркта миокарда. Часть 1 Российский кардиологический журнал 2017, 12 (152): 120–128 http://dx.doi.org/10.15829/1560-4071-2017-12-120-128)

Киношенко К.Ю., к.м.н., доцент; Мищук Н.Е., к.м.н., доцент Диастолическая дисфункция левого желудочка Ліки України • Medicine of Ukraine №8 (214) /2017. С.50-55.

Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Утверждены на Конгрессе ОССН 7 декабря 2012 года, на Правлении ОССН 31 марта 2013 и Конгрессе РКО 25 сентября 2013 года. Журнал Сердечная Недостаточность. 2013;14(7):379–472.

Татарченко И.П. проф., проф. Позднякова Н.В., к.м.н. Денисова А.Г., проф. Морозова О.И. Клинико-инструментальный анализ желудочковых нарушений ритма при диастолической сердечной недостаточности у больных сахарным диабетом 2-го типа. ПРОБЛЕМЫ ЭНДОКРИНОЛОГИИ, 2, 2015 doi: 10.14341/probl201561221-27.

Хохлова В.А. Диастолическая дисфункция левого желудочка у больных инфарктом миокарда. 2009год стр7.

Andersen O.S., Smiseth O.A., Dokainish H. et al.Estimating Left Ventricular Filling Pressure by Echocardiography//J. Am. Coll. Cardiol.–2017.–Vol. 69, №15.–P.1937–1048.

Burns R.J., Gibbons R.J., Yi Q., et al. The relationships of left ventricular ejection fraction, end systolic volume index and infarct size to six month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002; 39: 30-6. DOI: 10.1016/S0735-1097(01)01711-9.

Dagres N., Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Eur Heart J. 2013; 34 (26): 1964-71. DOI: 10.1093/eurheartj/eht109.

Eleonora Tashkenbaeva, Zarina Nasirova, Shuhrat Ziyadullaev, Kadirova Farzona. The Role of Biopsychosocial Risk Factors on the Intensification of Unstable Angina// Internatsional Journal of Advanced Science and Technology. Vol.29, No.5, (2020), pp.1948-1952.

Martsevich SYu, Ginzburg ML, Kutishenko NP, at al. Lyubertsy mortality study (LMS): factors influencing the long-term survival after myocardial infarction. Preventive Medicine 2013, 2, 32-8. (In Russ.) (Марцевич С. Ю., Гинзбург М. Л., Кутишенко Н. П. и др. Люберецкое исследование смертности (исследование ЛИС): факторы, влияю-щие на отдаленный прогноз жизни после перенесенного инфаркта миокарда. Профилактическая медицина, 2013, 2, 32-8).

Podolec P, Rubís P, tomkiewicz-Pajak L. Usefulness of the evaluation of left ventricular diastolic function changes during stress echocardiography in predicting exercise capacity in patients with ischemic heart failure. Journal of the American College of Cardiology. 2008 Jul; 21(7): 834-40. doi: 10.1016/j.echo.2007.12.008. Epub 2008 Jan 28

Sengeløv MG, Jensen JS, Bruun NE, Olsen FJ, FritzHansen T, Nochioka K et al. Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC: Cardiovasc Imag. 2015;8(12):1351–1359. http://dx. doi.org/10. 1016/j.jcmg.2015.0.013

Tashkenbaeva E.N., Ziyadullaev Sh. KH., Kamalov Z.S., Togaev D.Kh., Kadirova F.Sh., Abdieva G.A. Urate regulation gene polymorphisms are correlated with clinical forms of coronary heart disease// International journal of pharmaceutical research// Vol 11, Issue 3 July-Sept, 2019. P.198-202

Tashkenbaeva E.N., Rajabova N.T., Nasyrova Z.A., Kadirova F. Sh. Impact of lipid metabolism disorders and psychological risk factors on the development of cardiovascular disease among women of different age categories//Journal of Critical Reviews Vol:7, Issue: 12. 2020. P. 991-993

Tashkenbaeva E.N., Rajabova N.T., Nasyrova Z.A., Kadirova F. Sh. The impact of the cytokine imbalance on angina destabilization in women of different age categories// Academicia an international multidisciplinary research journal, Vol 10, Issue 6, June 2020. P. 732-738, DOI 10.5958/2249-7137.2020.00642.4

White HD, Norris RM, Brown MA, et al. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51. DOI: 10.1161/01.CIR.76.1.44.

Whalley GA, Gamble GD, Doughty RN. Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies. Heart 2006; 92: 1588-94. DOI: 10.1136/hrt.2005.083055.

Walter, J. Treatment of heart failure with normal ejection fraction an inconvenient truth! / J. Walter [et al.] // JACC. – 2010. – Vol. 55. – P. 526–537

Yancy C.W. et.al. 2017 ACC/AHA/HFSA Focused up date of the 2013 ACCF/AHA Guideline for management of heart failure // Circulation.2017.Vol.136.–e137–e161.

Yancy CW, Lopatin M, Stevenson LW et al.. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 2006; 47: 76-84.

Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001;87(3):320-3.

Published

2021-03-04